跳至主要内容
临床试验/CTRI/2020/06/026134
CTRI/2020/06/026134已完成1 期

A Physio-Pathological Study of Sharira Kleda in context to Prameha (Type 2 Diabetes) and its management with Trishna Nigrahana Mahakashaya - Prameha, Type 2 Diabetes

IPGT and RA GAU Jamnagar GujaratIPGT and RA GAU Jamnagar Gujarat0 个研究点目标入组 111 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
111

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients having classical signs and symptoms of Prameha and Type ââ?¬â?? 2 Diabetes.
  • Known patient of Type 2 Diabetes and also the preliminarily diagnosed patients on the basis of signs and symptoms of the disease are confirmed by FBS and PPBS.
  • FBS ââ?°Â¥ 110 mg/dl to 250mg/dl and or
  • PPBS level ââ?°Â¥ 200 mg/dl to 300mg/dl

排除标准

  • 1)Patients age less than 18 year and more than 60 year.
  • 2)Patients having FBS level less than 110 mg/dl or more than 250mg/dl and or PPBS level less than 200 mg/dl or more than 300mg/dl.
  • 3)IDDM, Juvenile DM, Gestational DM
  • 4)Prameha pidika (Diabetic nonhealing wound), Systemic infection, active infection other than superficial mild skin infestation.
  • 5)Patients with severe complications like CVD, Nephropathy, Neuropathy, Retinopathy, Diabetic foot, fatal diabetic complication etc.
  • 6)Patients of any other severe illness.
  • 7)Other chronic debilitating diseases.
  • 8)Pregnant woman.

研究者

发起方
IPGT and RA GAU Jamnagar GujaratIPGT and RA GAU Jamnagar Gujarat

相似试验

A Physiological-Pathological Study of Sharira... | 临床试验